Renaissance BioScience Corp., a bioengineering front-runner catering to global industries ranging from agriculture and animal health to human medicine and food, has secured a patent from the China patent office for its unique yeast-based platform that focuses on the production and delivery of RNA bioactive molecules. This latest acknowledgment extends the company's significant intellectual property portfolio, which already boasts 50 other patents and 11 more pending applications in various global markets, all of which show promising prospects.

The primary use of Renaissance's innovative yeast containing RNA bioactive molecules is in the design of biological products. These products take a nuanced, targeted approach to pest control, a noteworthy leap in the extensive international pest-control industry. China's pivotal role in this sector—both as the leading consumer of pesticides and as the dominant global producer of biopesticides—emphasizes the significance of this patent approval. Moreover, the technology's safety and efficacy underscore its potential value in vast market applications, notably in animal health and human medicine sectors.

Reflecting on this achievement, Dr. John Husnik, the company’s Chief Science Officer and a member of the CEO office, stated, “Securing a patent for our team’s innovative yeast-based RNA platform technology is truly a milestone achievement for Renaissance BioScience. China is an extremely large global market, and the many different large-scale biopesticide, animal health, and human medicine applications for this technology represent vast potential markets, not only in China but also in many other parts of the world, as other patents are awarded. We’re pleased and excited to receive this first patent that recognizes the benefits offered by this dynamic yeast-based RNA technology.”

Renaissance's new solution addresses several pressing issues in the realm of RNA delivery technologies:

• Stability: The hardy exterior of yeast cells is an ideal protector for the delicate RNA bioactive molecules, enhancing their viability in various conditions.
• Manufacturing: The production of yeast—cost-effective and of high quality—by general yeast manufacturers translates into a more affordable manufacturing process for the invaluable RNA bioactive molecules across diverse applications.
• Adaptability: The company's scientists possess the expertise to fine-tune the platform yeast, achieving a range of goals that include introducing multiple gene targets and combining with other compounds to augment its efficacy in varied applications.
• Safety: The foundation of the technology is a food-grade baker’s yeast, which is inactivated before use, assuring its safety and potentially simplifying regulatory processes.

RNA is fundamental to human life. There's a plethora of RNA types, all vital to every living organism, including the natural foods in our diets. Renaissance's biopesticides, for instance, employ RNA interference (RNAi) to target proteins crucial to a pest's survival specifically. A salient aspect of RNAi is its non-additive nature: it can only deactivate or "interfere with" existing functionalities by suppressing a gene's target activity. When these particular genes are deactivated by the RNAi, it results in the pest's death. Significantly, this precision-focused yeast-based RNAi does not adversely affect other insects, animals, humans, or plants, given the species-specific nature of the targeted genes.